Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors

被引:93
作者
Nuyttens, Joost J. [1 ]
van Zyp, Noelle C. van der Voort [1 ]
Praag, John [1 ]
Aluwini, Shafak [1 ]
van Klaveren, Rob J. [2 ]
Verhoef, Cornelis [4 ]
Pattynama, Peter M. [3 ]
Hoogeman, Mischa S. [1 ]
机构
[1] Erasmus MC Daniel den Hoed Canc Ctr, Dept Radiat Oncol, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus MC Daniel den Hoed Canc Ctr, Dept Pulmonol, NL-3000 CA Rotterdam, Netherlands
[3] Groene Hart Ziekenhuis, Dept Radiol, Gouda, Netherlands
[4] Erasmus MC Daniel den Hoed Canc Ctr, Dept Surg Oncol, NL-3000 CA Rotterdam, Netherlands
关键词
Stereotactic radiotherapy; Lung cancer; Central tumors; Real-time tumor tracking; BODY RADIATION-THERAPY; STAGE-I; PHASE-II; TRACKING SYSTEM; CANCER; ACCURACY; FAILURE; RISK; DISTANT; SBRT;
D O I
10.1016/j.radonc.2011.12.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To assess local control, overall survival, and toxicity of four-dimensional, risk-adapted stereotactic body radiotherapy (SBRT) delivered while tracking respiratory motion in patients with primary and metastatic lung cancer located in the central chest. Methods: Fifty-eight central lesions of 56 patients (39 with primary, 17 with metastatic tumors) were treated. Fifteen tumors located near the esophagus were treated with 6 fractions of 8 Gy. Other tumors were treated according to the following dose escalation scheme: 5 fractions of 9 Gy (n = 6), then 5 fractions of 10 Gy (n = 15), and finally 5 fractions of 12 Gy (n = 22). Results: Dose constraints for critical structures were generally achieved; in 21 patients the coverage of the PTV was reduced below 95% to protect adjacent organs at risk. At a median follow-up of 23 months, the actuarial 2-years local tumor control was 85% for tumors treated with a BED > 100 Gy compared to 60% for tumors treated with a BED <= 100 Gy. No grade 4 or 5 toxicity was observed. Acute grade 1-2 esophagitis was observed in 11% of patients. Conclusion: SBRT of central lung lesions can be safely delivered, with promising early tumor control in patients many of whom have severe comorbid conditions. (c) 2012 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 102 (2012) 383-387
引用
收藏
页码:383 / 387
页数:5
相关论文
共 25 条
  • [1] Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: Patterns of failure
    Andratschke, Nicolaus
    Zimmermann, Frank
    Boehm, Eva
    Schill, Sabine
    Schoenknecht, Christine
    Thamm, Reinhard
    Molls, Michael
    Nieder, Carsten
    Geinitz, Hans
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 101 (02) : 245 - 249
  • [2] STEREOTACTIC BODY RADIATION THERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CANCER: THE PATTERN OF FAILURE IS DISTANT
    Bradley, Jeffrey D.
    El Naqa, Issam
    Drzymala, Robert E.
    Trovo, Marco
    Jones, Griffin
    Denning, Mary Dee
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (04): : 1146 - 1150
  • [3] PROSPECTIVE, RISK-ADAPTED STRATEGY OF STEREOTACTIC BODY RADIOTHERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CANCER: RESULTS OF A PHASE II TRIAL
    Bral, Samuel
    Gevaert, Thierry
    Linthout, Nadine
    Versmessen, Harijati
    Collen, Christine
    Engels, Benedikt
    Verdries, Douwe
    Everaert, Hendrik
    Christian, Nicolas
    De Ridder, Mark
    Storme, Guy
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (05): : 1343 - 1349
  • [4] STEREOTACTIC BODY RADIATION THERAPY IN CENTRALLY AND SUPERIORLY LOCATED STAGE I OR ISOLATED RECURRENT NON-SMALL-CELL LUNG CANCER
    Chang, Joe Y.
    Balter, Peter A.
    Dong, Lei
    Yang, Qiuan
    Liao, Zhongxing
    Jeter, Melenda
    Bucci, M. Kara
    McAleer, Mary F.
    Mehran, Reza J.
    Roth, Jack A.
    Komaki, Ritsuko
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (04): : 967 - 971
  • [5] Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications
    Chi, Alexander
    Liao, Zhongxing
    Nguyen, Nam P.
    Xu, Jiahong
    Stea, Baldassarre
    Komaki, Ritsuko
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 94 (01) : 1 - 11
  • [6] STEREOTACTIC BODY RADIATION THERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CARCINOMA: FOUR-YEAR RESULTS OF A PROSPECTIVE PHASE II STUDY
    Fakiris, Achilles J.
    McGarry, Ronald C.
    Yiannoutsos, Constantin T.
    Papiez, Lech
    Williams, Mark
    Henderson, Mark A.
    Timmerman, Robert
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : 677 - 682
  • [7] DOSE-RESPONSE RELATIONSHIP FOR IMAGE-GUIDED STEREOTACTIC BODY RADIOTHERAPY OF PULMONARY TUMORS: RELEVANCE OF 4D DOSE CALCULATION
    Guckenberger, Matthias
    Wulf, Joern
    Mueller, Gerd
    Krieger, Thomas
    Baier, Kurt
    Gabor, Manuela
    Richter, Anne
    Wilbert, Juergen
    Flentje, Michael
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (01): : 47 - 54
  • [8] CLINICAL ACCURACY OF THE RESPIRATORY TUMOR TRACKING SYSTEM OF THE CYBERKNIFE: ASSESSMENT BY ANALYSIS OF LOG FILES
    Hoogeman, Mischa
    Prevost, Jean-Briac
    Nuyttens, Joost
    Poell, Johan
    Levendag, Peter
    Heijmen, Ben
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (01): : 297 - 303
  • [9] Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer
    Lagerwaard, Frank J.
    Haasbeek, Cornelis J. A.
    Smit, Egbert F.
    Slotman, Ben J.
    Senan, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (03): : 685 - 692
  • [10] Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors
    Le, Quynh-Thu
    Loo, Billy W.
    Ho, Anthony
    Cotrutz, Christian
    Koong, Albert C.
    Wakelee, Heather
    Kee, Stephen T.
    Constantinescu, Dana
    Whyte, Richard I.
    Donington, Jessica
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (08) : 802 - 809